A rabbit dilated cardiomyopathy model was used.
Mesenchymal cell (MSC) transplantation may be promising for dilated cardiomyopathy.
Platelet-rich plasma (PRP) should be further studied before its use in dilated cardiomyopathy.
Further investigations are required to understand the mechanisms of MSC transplantation.